Gheuens Sarah bought AGIO
April 2, 2026 · Form 4 insider transaction
Gheuens Sarah bought 8,500 shares of Agios Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,500
Price
$0.00
Total value
N/A
InsiderGheuens Sarah
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateApril 2, 2026
Filing dateApril 6, 2026
Shares owned after83,217
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 311 shares purchased through the Company's employee stock purchase plan.